证券代码：002254 股票简称：泰和新材 公告编号：2025-032 泰和新材集团股份有限公司 决议公告：2025-032 第十一届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 泰和新材集团股份有限公司第十一届董事会第十五次会议（临时会议）于 2025 年 5 月 12 日以现场加通讯方式召开。本次会议由董事长宋西全先生召集， 副董事长徐立新先生主持，会议通知于 2025 年 4 月 30 日以专人送达和电子邮件 等方式发出。会议应到董事 11 名，实到董事 11 名，其中，董事长宋西全先生、 董事马千里先生、刘勋章先生、李贺先生、齐贵山先生、程永峰先生、王吉法先 生、唐长江先生以通讯方式出席会议，符合有关法律、行政法规、部门规章和《公 司章程》的规定。公司监事和高级管理人员列席本次会议。会议通过以下决议： 1、以 7 票同意、0 票弃权、0 票反对，通过《关于公司 2022 年限制性股票 激励计划第二个限售期解除限售条件未成就暨回购注销部分限制性股票及调整 回购价格的议案》。 董事宋西全先生、迟海平先生、徐立新先生、马千里先生 ...

临时公告：2025-034 1、本次回购注销 2022 年限制性股票激励计划的限制性股票数量为 5,732,600 股，回购注销完成后，公司总股本由 862,945,783 股变更为 857,213,183 股。 2、根据公司 2024 年度权益分派计划，公司 2022 年限制性股票激励计划授 予的限制性股票的回购价格由 8.65 元/股调整为 8.60 元/股。 3、本次回购注销部分限制性股票事项尚需提交公司股东大会审议。 泰和新材集团股份有限公司（以下简称"公司"或"泰和新材"）于 2025 年 5 月 12 日召开第十一届董事会第十五次会议和第十一届监事会第十三次会议，审议 通过《关于公司 2022 年限制性股票激励计划第二个限售期解除限售条件未成就 暨回购注销部分限制性股票及调整回购价格的议案》，公司 2024 年度业绩指标 未达到《公司 2022 年限制性股票激励计划》（以下简称《激励计划》）第二个 解除限售期设定的公司层面业绩考核条件，公司拟回购注销激励计划首次授予和 预留授予的 388 名激励对象持有的限制性股票 566.10 万股。同时，首次授予的 6 名激励对象、预留授予的 2 名激励对象因 ...

Somore 山东松茂律师事务所 法律意见书 山东松茂律师事务所 关于泰和新材集团股份有限公司回购、注销 2022 年限制性股票激励计划部分限制性股票的 法律意见书 致:泰和新材集团股份有限公司 山东松茂律师事务所（以下简称"本所"）是具有中华人民共和 国（以下简称"中国"）法律执业资格的律师事务所。根据泰和新材 集团股份有限公司（以下简称"泰和新材"或"公司"）与本所签订 的法律服务协议，本所就泰和新材 2022 年限制性股票激励计划项目 （以下简称"本激励计划"）提供专项法律服务，现就本次公司回购、 注销部分限制性股票（以下简称"本次回购注销")的相关事项出具 本法律意见书。 本所依据《中华人民共和国公司法》(以下简称《公司法》)、《中 华人民共和国证券法》(以下简称《证券法》)、中国证券监督管理委 员会(以下简称"中国证监会")《上市公司股权激励管理办法》(以 下简称《管理办法》)、深圳证券交易所(以下简称"深交所")《深 圳证券交易所股票上市规则》(以下简称《上市规则》)、《深圳证券 交易所上市公司自律监管指南第 1 号——业务办理》（以下简称《自 律监管指南》）及适用的其他中国法律、行政法规、部门规 ...

法律意见书 山东齐鲁（烟台）律师事务所 关于泰和新材集团股份有限公司 2024 年度股东大会的法律意见书 致：泰和新材集团股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国公司 法》（以下简称"《公司法》"）和中国证券监督管理委员会（以下简称"中国证监会"） 关于《上市公司股东会规则》（以下简称"《股东会规则》"）等法律、法规和规范性文 件的要求，山东齐鲁（烟台）律师事务所（以下简称"本所"）接受泰和新材集团股份 有限公司（以下简称"公司"）委托，指派本所律师出席公司 2024 年度股东大会（以 下简称"本次股东大会"），并出具本法律意见书。 为出具本法律意见书，本所律师对公司本次股东大会所涉及的有关事项进行了审 查，查阅了公司本次股东大会的有关文件和材料，并对有关问题进行了必要的核查和 验证。本所律师得到公司如下保证，即其已提供了本所律师认为出具本法律意见书所 必需的材料，所提供的原始文件、副本、复印件等书面材料、口头证言均符合真实、 准确、完整的要求，有关副本、复印件材料与正本原始材料一致。 在本法律意见书中，本所律师根据《股东会规则》的要求，仅对公司本次股东大 会的召 ...

Investment Rating - The report maintains a positive outlook on the chemical industry, particularly highlighting undervalued and high-growth opportunities [1]. Core Insights - The anti-dumping duties on chlorpyrifos are expected to benefit domestic companies, with a recommendation to focus on Yangnong Chemical [3][4]. - The report emphasizes the importance of orderly exports of nitrogen fertilizers, suggesting that leading domestic companies should adopt a proactive pricing strategy to avoid excessive competition [3]. - The chemical sector is experiencing a gradual recovery in PPI, with a focus on investment opportunities in cyclical products due to low inventory levels [3][4]. Summary by Sections Industry Dynamics - Current macroeconomic conditions indicate a mixed outlook for oil, coal, and natural gas prices, with oil prices supported by shale oil production costs [3][4]. - The report notes a significant price increase in PTA and MEG, driven by supply constraints and optimistic market sentiment [9][10]. Fertilizer and Pesticide Market - Domestic urea prices have risen by 2.8% to 1830 CNY/ton, influenced by export policy expectations [11]. - The report highlights the stable pricing of various pesticides, with specific price points for glyphosate and other herbicides remaining unchanged [11]. Chemical Products Pricing - The report provides detailed pricing trends for various chemical products, including a 1.6% decrease in PVC prices and stable pricing for other chemicals like DMC and silicone [12][13]. - The report indicates a cautious market sentiment in the dye industry, with prices remaining stable despite cost support from raw materials [15]. Key Company Valuations - The report includes a valuation table for key companies, with recommendations for stocks such as Yangnong Chemical (buy) and Hualu Chemical (increase) based on their projected earnings and market performance [17][18].

Summary of the Conference Call for Taihe New Materials Group Co., Ltd. Company Overview - Taihe New Materials Group Co., Ltd. was established in 1987 and focuses on high polymer new material technology [3][6] - The company adheres to values of customer-centricity, open collaboration, integrity, innovation, and excellence [3] - It aims to empower a better life through technological innovation and industry chain services, becoming a leader in the high-performance fiber industry [3] - The company has expanded into six new sectors: new energy vehicles, smart wearables, green manufacturing, information communication, bio-based materials, and green chemicals [3] Key Points Discussed Industry Position and Strategy - The company is a state-controlled mixed-ownership enterprise, with the largest shareholder being a state-owned entity [7][8] - The company has a production capacity of approximately 100,000 tons for spandex and 16,000 tons each for meta-aramid and para-aramid fibers [6] - Since 2021, the company has been focusing on upstream and downstream technologies related to aramid fibers, including the production of aramid-coated membranes and green dyeing technologies [6] Market Dynamics - The impact of US-China trade tensions is minimal on direct exports to the US, as the company has low revenue from this market since 2021 [10] - Indirectly, trade tensions may accelerate domestic substitution, particularly affecting downstream demand for spandex and aramid fibers [10] - The company is experiencing overcapacity in the spandex sector, which is heavily investment-driven [12] Future Growth and Development - The company is focusing on expanding its aramid fiber business, which is seen as a key growth area [14] - There is potential for increasing market share in aramid fibers to between 50% and 70% through new business initiatives and expanding application spaces [23] - The company is also exploring international markets, with plans for local supply through warehouses abroad, although there are no immediate plans for overseas production bases [19][22] Product Development and Innovation - The company is working on enhancing production efficiency in the spandex sector and exploring the possibility of divesting this segment [34] - New product lines, such as smart fibers and green dyeing technologies, are in development, with a focus on market introduction and customer testing [31][33] - The company is also investing in upstream raw material production to stabilize quality and reduce costs [38] Financial Performance - The profitability of the spandex segment has declined significantly, while aramid fiber profits have shown slight growth [13][34] - The company is currently experiencing stable raw material supply and prices, with production rates for meta-aramid fibers exceeding 80% [39] Additional Insights - The company is actively pursuing internationalization strategies, including hiring overseas staff for local sales [41] - The competitive landscape is characterized by price wars in the spandex market, prompting the company to focus on structural and performance adjustments [43] - The company is committed to maintaining a diverse product structure to adapt to market changes and competition [42]

Group 1: Company Overview - The company was established in 1987, initially focusing on spandex production, with a current capacity of approximately 100,000 tons [2] - The company has diversified into aramid fibers, with production capacities of 16,000 tons for meta-aramid and 16,000 tons for para-aramid, both achieved in 2004 and 2011 respectively [2] - New products include aramid-coated membranes with a production capacity of 30 million square meters, launched in 2023, and a green dyeing demonstration line aimed at reducing water and carbon usage [2] Group 2: Market Position and Challenges - The company is state-controlled, with the largest shareholder being a state-owned entity [3] - Direct exports to the U.S. are minimal, with less than 10% of revenue coming from this market since 2021, indicating limited direct impact from U.S.-China trade tensions [3] - The company faces indirect impacts from trade tensions, particularly affecting downstream demand for spandex and aramid fibers [3] Group 3: Product Development and Future Directions - The company aims to enhance its market share in aramid fibers, with potential growth in specific segments estimated between 50% to 70% [4] - The company is exploring overseas expansion, with existing warehouses abroad to facilitate local supply [4] - Future product lines will focus on advanced textiles, safety protection, new energy, and chemicals, with ongoing research in smart fibers and membrane technology [4][5] Group 4: Financial Performance and Production Efficiency - The company reports a high operating rate for meta-aramid fibers at over 80%, while para-aramid is slightly lower [6] - The company is working on improving production efficiency for spandex to mitigate profit declines, which are significantly influenced by this segment [5][6] - The company is also assessing the stability of raw material supply, with a focus on reducing costs through new investments and technology [6] Group 5: Strategic Initiatives - The company is prioritizing domestic production to accelerate local replacements and is planning international sales expansions [6] - Adjustments in product structure and differentiation strategies are being considered to address price competition in the spandex market [7] - The company is committed to enhancing its competitive edge through technological advancements and expanding its product offerings in response to market demands [7]

Investment Rating - The investment rating for the company is "Buy" (maintained) with a target price of 10.75 CNY per share [1][5]. Core Views - The company's aramid business is experiencing steady growth, while the spandex segment is under pressure due to ongoing supply-demand imbalances and price competition [4][10]. - The forecast for the company's net profit for 2025-2027 has been adjusted to 222 million, 292 million, and 361 million CNY respectively, reflecting a significant downward revision from previous estimates [5][10]. - The company is expected to maintain a strong position in the aramid market, which has a projected compound annual growth rate of 5-10% globally, despite current price competition [10]. Financial Summary - The company reported a revenue of 3,925 million CNY in 2023, with a slight increase to 3,929 million CNY in 2024, and projected revenues of 4,494 million CNY in 2025, 4,938 million CNY in 2026, and 5,359 million CNY in 2027, indicating a growth trajectory [7][13]. - The net profit attributable to the parent company is forecasted to decline significantly in 2024 to 90 million CNY, before rebounding to 222 million CNY in 2025, reflecting a growth of 147.9% [7][10]. - The gross margin is expected to improve from 16.0% in 2024 to 21.4% by 2027, indicating a recovery in profitability [7][10]. Segment Performance - The spandex segment is projected to face continued challenges, with a forecasted gross margin of -11.86% in 2024, while the aramid segment is expected to see a 13% increase in sales volume [10]. - The company is advancing its aramid-coated diaphragm industrialization process, with pilot projects already in production and full-scale production expected to begin in 2025 [10].

Investment Rating - The investment rating for the company is "Buy" (maintained) with a target price of 10.75 CNY per share [1][5]. Core Views - The report highlights that the aramid business is steadily growing, while the spandex segment is under pressure due to ongoing supply-demand imbalances and price competition [4][9]. - The company has adjusted its profit forecasts for 2025-2027, with expected net profits of 222 million, 292 million, and 361 million CNY respectively, reflecting a significant downward revision from previous estimates [5][9]. Financial Performance Summary - The company reported a revenue of 3,925 million CNY in 2023, with a slight increase to 3,929 million CNY in 2024, and projected revenues of 4,494 million CNY in 2025, 4,938 million CNY in 2026, and 5,359 million CNY in 2027, indicating a growth rate of 14.4% in 2025 [7][12]. - The net profit attributable to the parent company is expected to recover from 90 million CNY in 2024 to 222 million CNY in 2025, showing a year-on-year growth of 147.9% [5][12]. - The gross margin is projected to improve from 16.0% in 2024 to 21.4% in 2027, while the net margin is expected to rise from 2.3% in 2024 to 6.7% in 2027 [7][12]. Segment Analysis - The spandex segment is facing challenges with a projected gross margin of -11.86% in 2024, leading to further losses [9]. - The aramid segment is expected to maintain a growth trajectory, with a 13% increase in sales volume in 2024 despite a decline in revenue and gross profit due to intensified price competition [9]. - The company is advancing its aramid-coated diaphragm industrialization process, with pilot projects already in production and full-scale production expected to commence in 2025 [9].

Core Insights - The company reported a slight increase in revenue for 2024, reaching 3.93 billion yuan, but a significant decline in net profit, down 73.1% to 90 million yuan [1] - The first quarter of 2025 showed a revenue increase of 9.4% year-on-year, totaling 1.06 billion yuan, but net profit fell by 54.1% to 10 million yuan [1] - The spandex segment continues to face pressure with a gross margin decline of 11.86%, exacerbating losses [1] Segment Analysis - The aramid segment saw a 13% increase in sales volume, maintaining strong growth, but revenue and gross margin decreased by 5.8% and 15.8% respectively due to intensified price competition [1] - The global aramid market is projected to grow at a compound annual growth rate of 5-10%, indicating potential for future expansion [1] - The company is advancing the industrialization of aramid-coated membranes, with pilot projects completed in March 2023 and full-scale production expected to begin in 2025 [1] Market Conditions - The domestic spandex market is experiencing a supply-demand imbalance, with new production capacity expected to increase by 11,500 tons in 2024, a 9.3% year-on-year rise [2] - Spandex profits are under pressure, but prices showed signs of recovery towards the end of Q1 due to industry maintenance and shutdowns [2] - The company has adjusted its profit forecasts for 2025-2027, with expected net profits of 222 million, 292 million, and 361 million yuan respectively [2]